Abciximab following clopidogrel reduces post-PCI complications in patients with acute coronary syndromes: Commentary

Nature Clinical Practice Cardiovascular Medicine

Volumn 3, Issue 12, 2006, Pages 650-651

  Keeley, Ellen C ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; PLACEBO; TIROFIBAN; TROPONIN;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; BLEEDING; CLINICAL TRIAL; CONFIDENCE INTERVAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DRUG EFFICACY; DRUG PROTEIN BINDING; DRUG SAFETY; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INCIDENCE; META ANALYSIS; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK REDUCTION; SHORT SURVEY; ST SEGMENT ELEVATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOGENESIS;

EID: 33751353421     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio0706     Document Type: Short Survey

References (5)

1. Braunwald E et al. (2002) ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - summary article: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 40: 1366-1374
2. Schulman SP (2004) Antiplatelet therapy in non-ST-segment elevation acute coronary syndromes. JAMA 292: 1875-1882
3. Boersma E et al. (2002) Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: A meta-analysis of all major randomised clinical trials. Lancet 359: 189-198
4. Kastrati A et al. (2004) A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N Engl J Med 350: 232-238
5. Antman EM et al. (2000) The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 284: 835-842